Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection

HBV infection in Italy is frequently underestimated, raising the risk of important complications, such as cirrhosis and hepatocellular carcinoma, and thus increasing mortality. In infections phases requiring treatment, it’s possible to choose among the currently available drugs: interferons, nucleos...

Full description

Bibliographic Details
Main Author: Mario Eandi
Format: Article
Language:English
Published: SEEd Medical Publishers 2011-06-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/72